Press Releases

Wilmington, Del., March 22, 2023 - Ashland and University College Dublin (UCD) will host biofilm resistant materials for hard tissue i mplant applications (BIOREMIA) European Training Network’s second Industrial Workshop, ‘Commercialisation of Research Outcomes.’  The project’s industrial and

Company actions drive gender parity WILMINGTON, Del., March 08, 2023 (GLOBE NEWSWIRE) -- In recognition of International Women’s Day, Ashland Inc. (NYSE: ASH) is celebrating, recognizing, and honoring the achievements of 22 female employee solvers across the company with regional awards

WILMINGTON, Del., March 6, 2023 – Ashland’s life sciences laboratory in Hyderabad, India has attained ISO 17025:2017 certification, an international standard for laboratory management that sets the requirements for a laboratory's competence, impartiality, and consistent operation.

Wilmington, Del., February 21, 2023 - Ashland is launching Benecel ™ MX 100 methylcellulose designed for high-volume, large-scale production efficiency for meat alternative products while providing consumers an enhanced eating experience. The innovative product for the nutrition industry broadens

Sales of $525 million, up three percent from the prior-year quarter Net income (including discontinued operations) of $40 million, or $0.73 per diluted share Income from continuing operations of $42 million, or $0.76 per diluted share Adjusted income from continuing operations excluding intangibles

WILMINGTON, Del., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today provided an update for preliminary fiscal 2023 first-quarter financial results 1 and maintained its outlook for fiscal year 2023 results. Additional information regarding first-quarter fiscal 2023 earnings and

WILMINGTON, Del., Jan. 23, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.335 cents per share on the company's common stock. The dividend is payable on March 15, 2023, to stockholders of record at the close of business on

WILMINGTON, Del., January 23, 2023 - Ashland is excited to announce the launch of The Natural Line for personal care products. This line is focused on promoting natural ingredients that can be easily recognized by their name, INCI description and have a defined composition.

WILMINGTON, Del., January 17, 2023 – Ashland has launched saffragyl ™ biofunctional that transforms oral health into a daily beauty regimen by proposing a natural, safe, and effective bioactive to take care of the biology of the gingiva. Saffragyl ™ biofunctional is a new, COSMOS approved cosmetic

WILMINGTON, Del., Nov. 18, 2022 (GLOBE NEWSWIRE) --  The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.335 cents per share on the company's common stock. The dividend is payable on December 15, 2022, to stockholders of record at the close of business on